HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation

被引:87
作者
Nie, Z
Phenix, BN
Lum, JJ
Alam, A
Lynch, DH
Beckett, B
Krammer, PH
Sekaly, RP
Badley, AD
机构
[1] Mayo Clin & Mayo Fdn, Div Infect Dis, Rochester, MN 55905 USA
[2] German Canc Res Ctr, Tumor Immunol Program, D-6900 Heidelberg, Germany
[3] Immunex Corp, Seattle, WA USA
[4] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada
[5] Ottawa Hlth Res Inst, Ottawa, ON, Canada
[6] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada
基金
加拿大健康研究院;
关键词
apoptosis; HIV; HIV-1; protease; caspase; 8; mitochondrial permeability transition pore complex; cytochrome c;
D O I
10.1038/sj.cdd.4401094
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infection of T cells with HIV-1 induces apoptosis and modulates apoptosis regulatory molecules. Similar effects occur following treatment of cells with individual HIV-1 encoded proteins. While HIV-1 protease is known to be cytotoxic, little is known of its effect on apoptosis and apoptosis regulatory molecules. The ability of HIV-1 protease to kill cells, coupled with the degenerate substrate specificity of HIV-1 protease, suggests that HIV-1 protease may activate cellular factor(s) which, in turn, induce apoptosis. We demonstrate that HIV-1 protease directly cleaves and activates procaspase 8 in T cells which is associated with cleavage of BID, mitochondrial release of cytochrome c, activation of the downstream caspases 9 and 3, cleavage of DFF and PARP and, eventually, to nuclear condensation and DNA fragmentation that are characteristic of apoptosis. The effect of HIV-1 protease is not seen in T cell extracts which have undetectable levels of procaspase 8, indicating a specificity and requirement for procaspase.
引用
收藏
页码:1172 / 1184
页数:13
相关论文
共 83 条
[1]   HIV-1 PROTEASE CLEAVES ACTIN DURING ACUTE INFECTION OF HUMAN LYMPHOCYTES-T [J].
ADAMS, LD ;
TOMASSELLI, AG ;
ROBBINS, P ;
MOSS, B ;
HEINRIKSON, RL .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) :291-295
[2]   Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus [J].
Alam, A ;
Braun, MY ;
Hartgers, F ;
Lesage, S ;
Cohen, L ;
Hugo, P ;
Denis, F ;
Sekaly, RP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) :1503-1512
[3]   FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
TOUGH, TW ;
DAVISSMITH, T ;
BRADDY, S ;
FALK, B ;
SCHOOLEY, KA ;
GOODWIN, RG ;
SMITH, CA ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :71-77
[4]   CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis [J].
Algeciras, A ;
Dockrell, DH ;
Lynch, DH ;
Paya, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) :711-720
[5]   Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis [J].
Andrade, F ;
Roy, S ;
Nicholson, D ;
Thornberry, N ;
Rosen, A ;
Casciola-Rosen, L .
IMMUNITY, 1998, 8 (04) :451-460
[6]   Mechanisms of HIV-associated lymphocyte apoptosis [J].
Badley, AD ;
Pilon, AA ;
Landay, A ;
Lynch, DH .
BLOOD, 2000, 96 (09) :2951-2964
[7]   Upregulation of fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes [J].
Badley, AD ;
McElhinny, JA ;
Leibson, PJ ;
Lynch, DH ;
Alderson, MR ;
Paya, CV .
JOURNAL OF VIROLOGY, 1996, 70 (01) :199-206
[8]   Macrophage-dependent apoptosis of CD4(+) T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor [J].
Badley, AD ;
Dockrell, D ;
Simpson, M ;
Schut, R ;
Lynch, DH ;
Leibson, P ;
Paya, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :55-64
[9]   CROSS-LINKING CD4 BY HUMAN IMMUNODEFICIENCY VIRUS-GP120 PRIMES T-CELLS FOR ACTIVATION-INDUCED APOPTOSIS [J].
BANDA, NK ;
BERNIER, J ;
KURAHARA, DK ;
KURRLE, R ;
HAIGWOOD, N ;
SEKALY, RP ;
FINKEL, TH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1099-1106
[10]   Apoptosis regulators from DNA viruses [J].
Barry, M ;
McFadden, G .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (04) :422-430